MIGLUSTAT

Generic: MIGLUSTAT

ANI PharmaceuticalsManufacturer
ORALRoute
MIGLUSTATActive Substance
2018-04-17Original Approval

MIGLUSTAT is FDA application ANDA208342, sponsored by ANI PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
SEIZURE
24 reports
2
DIARRHOEA
19 reports
3
PNEUMONIA
19 reports
4
PYREXIA
11 reports
5
OFF LABEL USE
10 reports
6
VOMITING
10 reports
7
DYSPHAGIA
9 reports
8
PNEUMONIA ASPIRATION
9 reports
9
RESPIRATORY FAILURE
9 reports
10
CONDITION AGGRAVATED
8 reports